Stay updated on Nivolumab for Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.

Latest updates to the Nivolumab for Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.2 was added. Prostate cancer and MedlinePlus Genetics-related topics, as well as Revision: v3.5.0, were removed.SummaryDifference0.2%

- Check12 days agoChange DetectedAdded related topics: Prostate cancer and MedlinePlus Genetics to the study page.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.5.0 was added, replacing Revision: v3.4.3.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.4.3 added; Prostate cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.2 were removed from the page.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded related topics 'Prostate cancer' and a link to 'MedlinePlus Genetics' to the page navigation.SummaryDifference0.2%

- Check69 days agoChange DetectedRevision: v3.4.2 was added, and the funding-lapse notice along with the prior Revision: v3.4.1 entry were removed.SummaryDifference0.4%

Stay in the know with updates to Nivolumab for Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.